Bull Run

India's AI-powered stock screener for NSE & BSE. 5,000+ stocks with fundamentals and real-time analysis.

info@bullrun.co.in

Navigate

  • Home
  • Smart Screener
  • Stock Battle Arena
  • Watchlist
  • Go Premium

Tools

  • Advanced Stock Screening
  • Stock Comparison Tool
  • Personal Watchlist
  • Ask AI Assistant
  • Browse All Stocks
  • IPO GMP Tracker
  • Market News & Blog

Indices

  • All Indices
  • Nifty 50 Stocks
  • Sensex Stocks
  • Nifty Bank
  • Nifty IT
  • Nifty Pharma
  • Nifty Midcap 100

Screeners

  • Top Dividend Stocks
  • Debt Free Stocks
  • Undervalued Stocks
  • High ROE Stocks
  • Low PE Stocks
  • Top Rated Stocks
  • Large Cap Stocks
  • Compare Stocks
  • Browse by Sector

Browse Stocks by Sector

View All →
Non Banking Financial Company (NBFC)PharmaceuticalsComputers - Software & ConsultingIndustrial ProductsCivil ConstructionAuto Components & EquipmentsSpecialty ChemicalsOther Financial ServicesIT Enabled ServicesPackagingHotels & ResortsCommodity ChemicalsOther Electrical EquipmentGarments & ApparelsPaper & Paper ProductsSoftware ProductsPackaged FoodsCement & Cement ProductsSugarHeavy Electrical EquipmentHospitalEdible OilPower GenerationHealthcare Service Provider
© 2026 Bull Run. All rights reserved.
AboutBlogPrivacy PolicyTerms of Service

Disclaimer: Ratings and scores are generated algorithmically from publicly available market data for educational and informational purposes only. They do not constitute investment advice or solicitation to buy/sell securities. Bull Run is not a SEBI-registered Research Analyst or Investment Adviser.

  1. Home
  2. /
  3. Sectors
  4. /
  5. Hospital
  6. /
  7. Jupiter Life Line Hospitals Limited
Financial RatiosPE RatioShareholdingDividendQuarterly ResultsBalance SheetProfit & LossCash Flow
HomeStocksHospitalJupiter Life Line Hospitals Limited

Jupiter Life Line Hospitals Limited Stock Price Today (NSE: JLHL)

Jupiter Life Line Hospitals Limited

JLHLHospital
₹1281.20+₹1.20 (+0.09%)↑
As on 30 Mar 2026, 12:06 pm ISTMarket Closed

Fundamental Score

...

Jupiter Life Line Hospitals Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Jupiter Life Line Hospitals Limited share price today is ₹1281.20, up +0.09% on NSE/BSE as of 30 March 2026. Jupiter Life Line Hospitals Limited (JLHL) is a Mid-cap company in the Hospital sector with a market capitalisation of ₹9.68K (Cr). The 52-week high for JLHL share price is ₹1625.00 and the 52-week low is ₹1198.80. At a P/E ratio of 48.76x, JLHL is currently trading below its industry average P/E of 52.84x. The company has a Return on Equity (ROE) of 14.95% and a debt-to-equity ratio of 0.28.

Jupiter Life Line Hospitals Limited Share Price Chart — NSE/BSE Historical Performance

No data
High
₹0.00
Low
₹0.00
Volume
0
Change
+0.09%

Returns & Performance

Poor

ROE

14.95%
Good

ROCE

17.95%
Excellent

OPM (5Y)

21.60%

Div Yield

0.07%

Jupiter Life Line Hospitals Limited Valuation Check

Average

P/E Ratio

48.76x
Poor

Industry P/E

52.84x
Market-cap Classification
Mid-cap
Balance of growth potential and stability.

Market Cap

9.68K (Cr)

Growth Engine

Poor

Profit Growth (Q)

11.04%
Good

Sales Growth (Q)

17.48%
Excellent

Sales Growth (5Y)

22.20%
Excellent

EPS Growth (5Y)

36.51%
Excellent

Profit Growth (5Y)

43.62%

Balance Sheet Health

Excellent

Debt to Equity

0.28x
Excellent

Int. Coverage

11.82x

Free Cash Flow (5Y)

-69.50 (Cr)

Shareholding

Excellent

Promoter

40.91%
Average

FII

9.06%
Good

DII

16.97%
Excellent

Pledged

0.00%

Institutional Deep-Dive

Bull Run Research Hub

Jupiter Life Line Hospitals Share Price: A Conservative Value Investor's Perspective

The healthcare sector is undergoing significant transformation, driven by an aging population and increasing demand for specialized medical services. This analysis examines the Jupiter Life Line Hospitals share price (₹1251.800048828125) from a conservative value investing perspective, focusing on capital safety and long-term sustainability. This is part of an 80-parameter fundamental audit verified by Sweta Mishra.

Currently, Jupiter Life Line Hospitals has a Price-to-Earnings (PE) ratio of 48.76. This valuation is relatively high, suggesting that the market has significant expectations for future growth. As value investors, we would need to assess if this growth is reasonably achievable and if the current Jupiter Life Line Hospitals share price appropriately reflects the inherent risks.

A key metric for evaluating a company's efficiency is its Return on Capital Employed (ROCE). Jupiter Life Line Hospitals boasts a ROCE of 17.95%. A consistently high ROCE, like this, can act as a moat, indicating that the company possesses a competitive advantage. In the hospital business, this might stem from specialized services, strong brand reputation, or efficient cost management. However, it's crucial to examine if this ROCE is sustainable in the face of rising operating costs and regulatory changes.

When comparing Jupiter Life Line Hospitals Limited to its peers, such as Nephro Care India Limited, we need to consider factors beyond just financial metrics. Management quality plays a vital role in the long-term success of a healthcare provider. Questions regarding executive compensation, strategic decision-making, and corporate governance become highly relevant. Evaluating the track record and experience of the management team at both Jupiter Life Line and Nephro Care India Limited is important in judging future success.

Finally, a conservative analysis demands scrutinizing the company’s debt levels, cash flow generation, and future capital expenditure requirements. The high PE ratio suggests some premium. For value investors concerned about capital safety, careful evaluation is important before deciding if the current Jupiter Life Line Hospitals share price offers an adequate margin of safety.

SM
Analysis by Sweta Mishra
SEBI Registered Research Analyst

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Jupiter Life Line Hospitals Limited Fundamental Analysis & Valuation Benchmarking

Educational evaluation of JLHL across key market metrics for learning purposes.

Positive Indicators

10 factors identified

Excellent ROCE Performance (17.95%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.

Strong Operating Margins (21.60%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages.

Strong Revenue Growth (17.48%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Consistent Growth Track Record (22.20% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.

Excellent EPS Growth (36.51% CAGR)

Observation: Outstanding 5-year earnings per share compound growth.

Analysis: EPS CAGR >15% indicates strong wealth creation potential.

Strong Profit Growth Track Record (43.62% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Conservative Debt Levels (D/E: 0.28)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Strong Interest Coverage (11.82x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Strong Institutional Confidence (FII+DII: 26.03%)

Observation: Significant professional investor participation.

Analysis: High institutional holding often signals thorough due diligence.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

2 factors identified

Premium Valuation Risk (P/E: 48.76x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.

Negative Free Cash Flow (₹-69.50 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

Jupiter Life Line Hospitals Limited Financial Statements

Comprehensive financial data for Jupiter Life Line Hospitals Limited including income statement, balance sheet and cash flow

About JLHL (Jupiter Life Line Hospitals Limited)

Jupiter Life Line Hospitals Limited is a sprawling network of healthcare institutions woven into the fabric of India's medical landscape. Beyond mere brick and mortar, these hospit...als stand as modern cathedrals of healing, places where cutting-edge technology intersects with compassionate care. Step inside, and you're met with a symphony of purposeful activity – the hushed murmur of consultations, the soft beeping of monitors, and the quiet reassurance offered by dedicated medical professionals. From the inviting lobbies adorned with calming art to the meticulously sterilized operating rooms, every detail is thoughtfully designed to foster an environment of trust and well-being. JLHL strives to be the destination where patients can embark on their journey towards recovery, guided by expertise and unwavering support. Within Jupiter Life Line Hospitals, a vast ecosystem of specialized medical disciplines coexists, forming a holistic approach to patient care. Each department functions as a center of excellence, staffed by teams of highly skilled physicians, surgeons, nurses, and technicians who are all dedicated to their craft. From complex cardiovascular procedures to delicate neurosurgical interventions, the breadth of services available is comprehensive. The hospital prides itself on early adoption of innovative medical techniques, and its continued investment in cutting edge medical advancements. This is coupled with a commitment to evidence-based practices, ensuring that patients receive the most effective and appropriate treatments available, tailored to their individual needs. More than just a provider of medical services, Jupiter Life Line Hospitals aspires to be a partner in the communities it serves. Recognizing that true health extends beyond the confines of the hospital walls, JLHL actively engages in outreach programs, health education initiatives, and community health screenings. By promoting preventative care and empowering individuals to take control of their own well-being, the hospital seeks to foster a culture of health and wellness that extends far beyond its immediate patient base. This commitment to community engagement underscores JLHL's belief that healthcare is a shared responsibility, and that by working together, the health and well-being of the entire community can be improved.

Company Details

Symbol:JLHL
Industry:Hospital
Sector:Hospital
Website:https://www.jupiterhospital.com

Key Leadership

Dr. Ajay Pratap Thakker
Chairman & MD
Dr. Ankit Ajay Thakker
Joint MD, CEO & Executive Director
Mr. Harshad Purani
CFO and President of Administration & Head of Corporate Social Responsibility

Corporate Events

Recent
Ex-Dividend Date
2025-07-04

JLHL Share Price: Frequently Asked Questions

What is the current share price of Jupiter Life Line Hospitals Limited (JLHL)?

As of 30 Mar 2026, 12:06 pm IST, Jupiter Life Line Hospitals Limited share price is ₹1281.20. The JLHL stock has a market capitalisation of ₹9.68K (Cr) on NSE/BSE.

Is JLHL share price Overvalued or Undervalued?

JLHL share price is currently trading at a P/E ratio of 48.76x, compared to the industry average of 52.84x. Based on this relative valuation, the Jupiter Life Line Hospitals Limited stock appears to be Undervalued against its sector peers.

What is the 52-week high and low of JLHL share price?

The 52-week high of JLHL share price is ₹1625.00 and the 52-week low is ₹1198.80. These values are updated daily from NSE/BSE price data.

What factors affect the Jupiter Life Line Hospitals Limited share price?

Key factors influencing JLHL share price include quarterly earnings growth (Sales Growth: 17.48%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).

Is Jupiter Life Line Hospitals Limited a good stock for long-term investment?

Jupiter Life Line Hospitals Limited shows a 5-year Profit Growth of 43.62% and an ROE of 14.95%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.28 before investing in JLHL shares.

How does Jupiter Life Line Hospitals Limited compare with its industry peers?

Jupiter Life Line Hospitals Limited competes with major peers in the Hospital. Investors should compare JLHL share price P/E of 48.76x and ROE of 14.95% against the industry averages to determine competitive standing.

What is the P/E ratio of JLHL and what does it mean?

JLHL share price has a P/E ratio of 48.76x compared to the industry average of 52.84x. Investors pay ₹49 for every ₹1 of annual earnings.

How is JLHL performing according to Bull Run's analysis?

JLHL has a Bull Run fundamental score of 62.9/100, indicating moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters.

What sector and industry does JLHL belong to?

JLHL operates in the Hospital industry. This classification helps understand the competitive landscape and sector-specific trends affecting Jupiter Life Line Hospitals Limited share price.

What is Return on Equity (ROE) and why is it important for JLHL?

JLHL has an ROE of 14.95%, which shows decent profitability but room for improvement. ROE measures how efficiently Jupiter Life Line Hospitals Limited generates profits from shareholders capital.

How is JLHL debt-to-equity ratio and what does it indicate?

JLHL has a debt-to-equity ratio of 0.28, which indicates conservative financing with low financial risk.

What is JLHL dividend yield and is it a good dividend stock?

JLHL offers a dividend yield of 0.07%, meaning you receive ₹0.07 annual dividend for every ₹100 invested in Jupiter Life Line Hospitals Limited shares.

How has JLHL share price grown over the past 5 years?

JLHL has achieved 5-year growth rates of: Sales Growth 22.20%, Profit Growth 43.62%, and EPS Growth 36.51%.

What is the promoter holding in JLHL and why does it matter?

Promoters hold 40.91% of JLHL shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Jupiter Life Line Hospitals Limited.

What is JLHL market capitalisation category?

JLHL has a market capitalisation of ₹9678 crores, placing it in the Mid-cap category.

How volatile is JLHL stock?

JLHL has a beta of N/A. A beta > 1 suggests the Jupiter Life Line Hospitals Limited stock is more volatile than the market, while a beta < 1 suggests it is less volatile.

What is JLHL operating profit margin trend?

JLHL has a 5-year average Operating Profit Margin (OPM) of 21.60%, indicating the company's operational efficiency.

How is JLHL quarterly performance?

Recent quarterly performance shows Jupiter Life Line Hospitals Limited YoY Sales Growth of 17.48% and YoY Profit Growth of 11.04%.

What is the institutional holding pattern in JLHL?

JLHL has FII holding of 9.06% and DII holding of 16.97%. Significant institutional holding often suggests professional confidence in the Jupiter Life Line Hospitals Limited stock.

HomeScreenerBattleWatchlist

Frequently Asked Questions about Jupiter Life Line Hospitals Limited

What is the current share price of Jupiter Life Line Hospitals Limited?

Jupiter Life Line Hospitals Limited (JLHL) trades at ₹1281.20 on NSE and BSE. Market cap ₹9.68K (Cr). Educational data only.

What is the P/E ratio of Jupiter Life Line Hospitals Limited?

Jupiter Life Line Hospitals Limited has a P/E of 48.76x vs industry average 52.84x.

What is the Bull Run score for Jupiter Life Line Hospitals Limited?

Jupiter Life Line Hospitals Limited has a Bull Run score of 62.9/100 based on 25+ financial parameters.

Does Jupiter Life Line Hospitals Limited pay dividends?

Jupiter Life Line Hospitals Limited has a dividend yield of 0.07%. Past dividends don't guarantee future payments.

What is the ROE of Jupiter Life Line Hospitals Limited?

Jupiter Life Line Hospitals Limited has ROE of 14.95%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Jupiter Life Line Hospitals Limited?

Jupiter Life Line Hospitals Limited has debt-to-equity of 0.28.

Is Jupiter Life Line Hospitals Limited a good investment?

Bull Run gives Jupiter Life Line Hospitals Limited a score of 62.9/100. This is not investment advice — consult a SEBI-registered advisor.